AU2002227925A1 - Human beta-defensin-3 - Google Patents

Human beta-defensin-3

Info

Publication number
AU2002227925A1
AU2002227925A1 AU2002227925A AU2792502A AU2002227925A1 AU 2002227925 A1 AU2002227925 A1 AU 2002227925A1 AU 2002227925 A AU2002227925 A AU 2002227925A AU 2792502 A AU2792502 A AU 2792502A AU 2002227925 A1 AU2002227925 A1 AU 2002227925A1
Authority
AU
Australia
Prior art keywords
defensin
human beta
beta
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002227925A
Inventor
Knut Adermann
Robert Bals
Jose-Ramon Conejo-Garcia
Wolf-Georg Forssmann
Enno Kluver
Hans-Jurgen Magert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPF Pharmaceuticals GmbH
Original Assignee
IPF Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPF Pharmaceuticals GmbH filed Critical IPF Pharmaceuticals GmbH
Publication of AU2002227925A1 publication Critical patent/AU2002227925A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002227925A 2000-11-14 2001-11-14 Human beta-defensin-3 Abandoned AU2002227925A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10056365.1 2000-11-14
DE10056365 2000-11-14
DE10116220.0 2001-03-30
DE10116220 2001-03-30
PCT/EP2001/013174 WO2002040512A2 (en) 2000-11-14 2001-11-14 Human beta-defensin-3

Publications (1)

Publication Number Publication Date
AU2002227925A1 true AU2002227925A1 (en) 2002-05-27

Family

ID=26007661

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002227925A Abandoned AU2002227925A1 (en) 2000-11-14 2001-11-14 Human beta-defensin-3

Country Status (2)

Country Link
AU (1) AU2002227925A1 (en)
WO (1) WO2002040512A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576755B1 (en) 1997-09-10 2003-06-10 Zymogenetics, Inc. Beta-defensins
US8691945B2 (en) 2006-04-27 2014-04-08 Singapore Health Services Pte Ltd. Antimicrobial peptides
EP2396023A2 (en) * 2009-02-11 2011-12-21 Yeda Research and Development Co. Ltd. Short beta-defensin-derived peptides
KR101257228B1 (en) * 2010-06-16 2013-04-29 주식회사 나이벡 Antibacterial or Anti-inflammatory Peptides and Pharmaceutical Composition Containing Thereof
CN102533857B (en) * 2012-02-21 2014-05-07 西北农林科技大学 HBD3 tracheal epithelium specificity expression vector and recombinant cell constructed from same
DK2976325T3 (en) 2013-03-21 2017-06-06 Sanofi Aventis Deutschland SYNTHESIS OF PEPTIDE PRODUCTS CONTAINING CYCLIC IMID
WO2014147124A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
EP2990415B1 (en) * 2014-08-29 2018-11-28 Ceinge Biotecnologie Avanzate S.C. a R.L. Cyclic beta defensins analogs for the treatment of infections
KR101693533B1 (en) 2015-03-26 2017-01-06 서울대학교산학협력단 Anti-Cancer Peptide for Inhibition of Proliferation on the Cancer Stem Cells and Use Thereof
KR102244161B1 (en) * 2018-08-31 2021-04-26 주식회사 나이벡 Use of Peptides having Ability to inhibit multiple disease biomarkers' expression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU744152B2 (en) * 1997-09-10 2002-02-14 Zymogenetics Inc. Beta-defensins
ATE291586T1 (en) * 1999-02-01 2005-04-15 Schering Ag HUMAN ANTIBIOTIC PROTEIN
US6809181B2 (en) * 2000-06-01 2004-10-26 University Of Iowa Research Foundation Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide
AU2001289641A1 (en) * 2000-07-11 2002-01-21 Ipf Pharmaceuticals Gmbh Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
CA2417331C (en) * 2000-07-28 2011-03-22 Christopher J. Murphy Transplant media comprising bnp-1

Also Published As

Publication number Publication date
WO2002040512A2 (en) 2002-05-23
WO2002040512A3 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001259702A1 (en) Tissue regrafting
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2002224553A1 (en) Human proteases
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2371201A (en) Endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2001270129A1 (en) Human phosphodiesterases
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU4456800A (en) Human hac3
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001262711A1 (en) Cytoprotectors
AU2001284173A1 (en) Calycins
AU2001260192A1 (en) Glycinamides